Trial Highlights Biomarker and Clinical Predictors of Long-Term Concussion Symptoms
Findings show that early symptom patterns and biomarker data may help forecast which mild traumatic brain injury patients will experience 30-day symptom persistence.
Latest Articles
Editor's Top Picks
FDA Clears Blood Test for Alzheimer’s Assessment in Primary Care
The test measures phosphorylated Tau 181 protein to help rule out Alzheimer's-related amyloid pathology in patients 55 and older.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Monod Bio Taps AI Protein Design to Build Rapid Point-of-Care Preeclampsia Test
The Seattle biotech company receives a $750,000 Gates Foundation grant to develop a rapid diagnostic using novel protein binders and a luciferase system.
Equipment & Supply Spotlight
Lonza Adds Cytokines and Viral Production Medium to Cell Therapy Portfolio
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
News, Know-How & Standards
Disease Detection & Understanding
Proscia Expands AI Capabilities to Support Skin Pathology Evaluation
New skin tissue analysis tools aim to address diagnostic challenges in one of pathology's most diverse specialties.
